The largest database of trusted experimental protocols

Hrp rabbit anti mouse igg h l

Manufactured by Thermo Fisher Scientific
Sourced in United States

The HRP-rabbit anti-mouse IgG (H + L) is a secondary antibody reagent designed for use in various immunoassay techniques. It consists of horseradish peroxidase (HRP) conjugated to rabbit-derived polyclonal antibodies that recognize both the heavy and light chains of mouse immunoglobulin G (IgG).

Automatically generated - may contain errors

4 protocols using hrp rabbit anti mouse igg h l

1

Immunoblot Analysis of DNA Damage Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblot analysis was carried out as described previously.46, 47 Antibodies specific for the following were used: MCM834; MCM934; Pan‐RAS (sc‐166691; Santa Cruz Biotechnology, Dallas, TX, USA); p53 (OP43; Calbiochem, Dallas, TX, USA); Chk1 (sc‐8408; Santa Cruz Biotechnology); phospho‐Chk1 Ser345 (#2348S; Cell Signaling Technology, Danvers, MA, USA); Chk2 (#05‐649; Upstate, Lake Placid, NY, USA); phospho‐Chk2 Thr68 (#2661; Cell Signaling Technology); phospho‐H2AX Ser139 (#07‐164; Millipore, Burlington, MA, USA); phospho‐ATM Ser1981 (#20772; Rockland, Limerick, PA, USA); and Rad51 (70‐012; Bio Academia, Osaka, Japan). The following secondary Abs were used: HRP‐rabbit anti‐mouse IgG (H + L) (61‐6520; Invitrogen, Carlsbad, CA, USA); HRP‐goat anti‐rabbit IgG (H + L) (65‐6120; Invitrogen); Alexa 594‐conjugated donkey anti‐rabbit IgG (H + L) (A21207; Invitrogen); and Alexa 488‐conjugated goat anti‐mouse IgG (H + L) (A11029; Molecular Probes, Eugene, OR, USA).
+ Open protocol
+ Expand
2

Immunoblotting of Cell Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was performed as described previously7 (link). Antibodies used in this study were as follows: NUP155 (A303-934A, Bethyl Laboratories), IPOβ (ab2811, Abcam), KNTC1 (F2051-10H4, Sigma-Aldrich), hCAP-D2 (E4161-4C12, Sigma-Aldrich), IPO7 (ab88339, Abcam), CLTC (sc-271178, Santa Cruz), Cdc2-phosphorylated vimentin Ser55 (D076-3, MBL), GST (G7781, Sigma-Aldrich), GFP (A6455, Invitrogen), and HA-tag (clone 3F10, Roche). Secondary antibodies were HRP-rabbit anti-mouse IgG (H + L) (61-6520, Invitrogen) or HRP-goat anti-rabbit IgG (H + L) (65–6120, Invitrogen).
+ Open protocol
+ Expand
3

FVIII-specific memory B cell differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from FVIII-immunized HA mice were depleted for CD138+ plasmablasts using CD138 microbeads (Miltenyi Biotec), and the resultant pooled CD138 splenocytes served as the source for FVIII-specific memory B cells (5 (link)–7 (link)). In 48-well culture plates, 6 × 10^6 of CD138 splenocytes were cultured with 40,000 of A2-BAR Tregs or A2-BAR Tcon cells in the presence of 10 ng/ml rFVIII at 37°C for 6 days to promote FVIII-specific memory B cells differentiation into anti-FVIII antibody-secreting cells (ASC). For the B-cell ELISPOT assay, after 6 days the cells were washed twice in culture medium and transferred to 5 μg/ml rFVIII-coated 96-well ELISPOT plates (EMD Millipore) and cultured overnight. The spots indicating FVIII-specific ASCs were visualized through incubation with HRP-rabbit anti-mouse IgG (H + L) (Thermo Fisher Scientific), followed by AEC substrate (BD Biosciences).
+ Open protocol
+ Expand
4

ELISPOT to Assess FVIII-Specific B Cell Suppression by BAR Tregs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure the FVIII-specific B cell suppression by BAR Tregs in vitro, an Enzyme-Linked ImmunoSpot (ELISPOT) protocol was used (14 (link)). As a model for inhibitor development in HA patients, anti-FVIII antibody response were established in E16 mice by weekly intravenous injection of 1 μg recombinant human FVIII in PBS for 4 weeks in most experiments. Pooled splenocytes (2 × 106) from four FVIII-immunized E16 mice were co-cultured with 1 × 105 of either A2-, C2-, or the control OVA-BAR human Tregs (BAR hTregs) in complete culture media. Two hours after mixing the Tregs and splenocytes to allow for potential interaction of specific B cells with the BARs, human rFVIII protein (0.1 μg/ml) was added and culture was continued for 5 days. The cells were washed twice in culture medium and transferred to 2 μg/ml rFVIII coated 96-well ELISPOT plates (EMD Millipore) and cultured overnight. The number of spots by FVIII-specific antibody secretion B cells (ASCs) was visualized by incubation with second antibody HRP-rabbit anti-mouse IgG (H+L) (ThermoFisher Scientific) followed by AEC substrate (BD Biosciences).
For measuring anti-FVIII total IgG antibody levels, an enzyme-linked immunosorbent assay (ELISA) was used as previously reported (15 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!